LDL cholesterol, often called “bad” cholesterol, is significant in heart health. It’s a waxy substance in the blood that can accumulate in artery walls, forming plaque. This plaque buildup, known as ...

Around 33% to 36% of adults in the U.S. have a lousy LDL cholesterol level of 130 mg/dL or higher, putting them at risk for a heart attack, stroke, peripheral vascular disease and dementia. Aiming for ...

Low-density lipoprotein (LDL), also known as the ‘bad’ cholesterol, is linked to increased risk of heart disease and stroke. High levels of LDL lead to the buildup of plaque in arteries, which further ...

A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered “bad” LDL cholesterol by more than half in a global study ...

Which is good cholesterol HDL or LDL and what are the key differences to know when understanding your cholesterol levels and heart health.

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...

I have seen 2 studies (the Treating to New Targets [TNT] trial and the Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound-Derived [ASTEROID] coronary atheroma burden trial) in ...

People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including lower risk of Alzheimer’s disease related dementia, shows a study ...

"Inclisiran, administered twice-yearly (after initial and 3-month doses) with maximum-tolerated statins or other oral lipid-lowering therapies, provide sustained and effective LDL cholesterol lowering ...